Thomas A Davis
Affiliation: National Institutes of Health
- The radioisotope contributes significantly to the activity of radioimmunotherapyThomas A Davis
Stanford University, Stanford, California, USA
Clin Cancer Res 10:7792-8. 2004....
- Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patientsJohn M Timmerman
Division of Oncology, Department of Medicine, Stanford University School of Medicine, CA, USA
Blood 99:1517-26. 2002..Subsequent boosting with Id-KLH can lead to tumor regression despite apparent resistance to the primary DC vaccine...
- Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanomaGiao Q Phan
Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
Proc Natl Acad Sci U S A 100:8372-7. 2003..This study establishes CTLA-4 as an important molecule regulating tolerance to "self" antigens in humans and suggests a role for CTLA-4 blockade in breaking tolerance to human cancer antigens for cancer immunotherapy...
- Patterns of care in a population-based random sample of patients diagnosed with non-Hodgkin's lymphomaDeirdre P Cronin
National Cancer Registry Ireland, Elm Court, Boreenmanna Rd, Cork, Ireland
Hematol Oncol 23:73-81. 2005..01). This is the first population-based study examining therapy received for many histological subtypes of NHL...